Co‐infection of malaria and dengue in pregnant women with SARS‐CoV‐2

Mahajan, Niraj N.; Kesarwani, Shweta; Shinde, Snehal; Nayak, Anurupa; Modi, Deepak; Mahale, Smita D.; Gajbhiye, Rahul

doi:10.1002/ijgo.13415

Cited by 42 publications

(62 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the sample size was too limited to draw any firm conclusions. Coinfection with malaria and dengue has been reported among pregnant women with COVID‐19 13 ; however, no coinfections were observed in the present cohort of women with MGP and COVID‐19.…”

Section: Discussioncontrasting

confidence: 71%

Impact of SARS‐CoV‐2 on multiple gestation pregnancy

Mahajan

Ansari

Gaikwad

et al. 2020

Intl J Gynecology & Obste

Self Cite

View full text Add to dashboard Cite

The incidence of multiple pregnancies varies in different populations and countries. Twinning rates in India are reported to be below 9 per 1000 births. 1 As of October 20, 2020 SARS-CoV-2 (COVID-19) had affected approximately 40 million individuals globally and caused more than 1 million deaths, 2 including many pregnant women with twin gestation. Multiple gestational pregnancies (MGP) are associated with a high risk of both fetal and maternal complications and require

show abstract

Section: Discussioncontrasting

confidence: 71%

Impact of SARS‐CoV‐2 on multiple gestation pregnancy

Mahajan

Ansari

Gaikwad

et al. 2020

Intl J Gynecology & Obste

Self Cite

View full text Add to dashboard Cite

show abstract

“…Indonesia reported the most cases of co-infection followed by Pakistan and India. Most co-infection was in adults [ 15 – 18 , 21 , 22 , 24 – 27 , 32 ] and only one study included a paediatric patient [ 23 ]. In terms of diagnosis, rapid diagnostic test (RDT) ( n = 8) [ 15 , 17 , 22 , 23 , 25 , 26 , 32 , 33 ], ELISA ( n = 3) [ 18 , 24 , 33 ] and RT-PCR ( n = 5) [ 15 , 16 , 21 , 22 , 27 ] were used for the diagnosis of dengue, while RDT ( n = 3) [ 17 , 21 , 23 ] and RT-PCR ( n = 11) [ 15 , 16 , 18 , 21 , 22 , 24 – 27 , 32 , 33 ] were used for COVID-19 (Table 1 ).…”

Section: Resultsmentioning

confidence: 99%

“…Most co-infections were reported in adults aged 18–69 years [ 15 – 18 , 21 , 22 , 24 – 27 , 32 ]. The youngest patient was a six-year old child [ 23 ].…”

Section: Resultsmentioning

confidence: 99%

“…The clinical records of 16 cases were extracted. Fever was present in all 16 patients [ 15 – 18 , 21 – 27 , 32 ]. Other clinical manifestations were dyspnea ( n = 10) [ 15 , 17 , 18 , 21 – 24 , 27 ], fatigue ( n = 7) [ 15 , 16 , 23 , 25 , 27 ], headache ( n = 9) [ 15 , 16 , 18 , 22 , 25 , 27 ] and cough ( n = 8) [ 15 , 18 , 22 , 24 , 26 , 27 ].…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review

et al. 2021

View full text Add to dashboard Cite

Background Dengue is the most common arboviral disease in the tropical and sub-tropical regions of the world. Like other regions, dengue-endemic areas have faced the additional public health and socio-economic impact of the ongoing coronavirus disease 2019 (COVID-19) pandemic. COVID-19 and dengue co-infections have been reported, with complicated patient management and care requirements. This review aimed to collate and synthesise current knowledge on the clinical features and outcomes of COVID-19 and dengue virus co-infection, a potentially important new dimension to be considered in public health management of the COVID-19 pandemic. Methods A systematic literature review was conducted using PubMed, Web of Science and Scopus databases from 1st January to 21st November 2020. The key search terms used were “dengue” and “coronavirus”. Descriptive analysis with graphical illustrations were used to present the clinical and laboratory parameters of the co-infection. Results Thirteen published papers and four news articles were included in the review. Most studies were case reports with a detailed description of the clinical and laboratory characteristics of the co-infection. All cases were in adults with the exception of a six-year old child. The common symptoms of co-infection were fever, dyspnea, headache, and cough. Common laboratory results included thrombocytopenia, lymphocytopenia, elevated transaminases, and leukopenia. Serious outcomes of co-infection included septic shock, acute respiratory disease syndrome and multi-organ failure, leading to death in some patients. Conclusions COVID-19 and dengue co-infection was associated with severe disease and fatal outcomes. The correct diagnosis and treatment of co-infection poses a substantial challenge due to the overlapping clinical and laboratory parameters. Therefore, confirmative diagnostic tests are necessary for accurate and timely diagnosis and patient management.

show abstract

“…The synchronous co‐infection of malaria and SARS‐CoV‐2 in pregnancy has recently been reported 1 . A 38‐year‐old woman born in Burkina Faso, gravida 4 para 3, lived in Italy for 8 years until November 2019 when she returned to Burkina Faso for a short visit.…”

mentioning

confidence: 95%